New 52 Week Low Today

Biogen Inc BIIB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
190.52UNCH (UNCH)
Volume
42,376
Close
190.52quote price arrow down-1.64 (-0.85%)
Volume
1,468,603
52 week range
189.52 - 319.76
Loading...
  • Open191.75
  • Day High192.56
  • Day Low189.52
  • Prev Close192.16
  • 52 Week High319.76
  • 52 Week High Date06/12/23
  • 52 Week Low189.52
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap27.694B
  • Shares Out145.36M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.03
  • YTD % Change-26.37

KEY STATS

  • Open191.75
  • Day High192.56
  • Day Low189.52
  • Prev Close192.16
  • 52 Week High319.76
  • 52 Week High Date06/12/23
  • 52 Week Low189.52
  • 52 Week Low Date04/18/24
  • Market Cap27.694B
  • Shares Out145.36M
  • 10 Day Average Volume0.99M
  • Dividend-
  • Dividend Yield-
  • Beta0.03
  • YTD % Change-26.37

RATIOS/PROFITABILITY

  • EPS (TTM)7.98
  • P/E (TTM)23.88
  • Fwd P/E (NTM)12.39
  • EBITDA (TTM)2.545B
  • ROE (TTM)8.24%
  • Revenue (TTM)9.836B
  • Gross Margin (TTM)74.24%
  • Net Margin (TTM)11.81%
  • Debt To Equity (MRQ)46.88%

EVENTS

  • Earnings Date04/24/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Profile

MORE
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include...
Caroline Dorsa
Independent Chairman of the Board
Christopher Viehbacher
President, Chief Executive Officer, Director
Michael McDonnell CPA
Chief Financial Officer, Executive Vice President
Nicole Murphy
Executive Vice President - Pharmaceutical Operations and Technology
Adam Keeney Ph.D.
Executive Vice President, Head of Corporate Development
Address
225 Binney Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
102.00-1.44-1.39%
ILMN
Illumina Inc
116.69-1.60-1.35%
BNTX
Biontech SE
86.17-0.23-0.27%
GRFS
Grifols SA
6.54-0.04-0.61%
CRL
Charles River Laboratories International Inc
227.55-2.54-1.10%